Nykode Therapeutics ASA (NYKD)
Market Closed
8 Dec, 14:20
XOSL 
kr
2. 61
+0.17
+6.89%
kr
351.77M Market Cap
- P/E Ratio
0% Div Yield
1,627,215 Volume
- Eps
kr 2.44
Previous Close Day Range
2.46 2.65
Year Range
1.44 3.55
Want to track NYKD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 78 days
Summary
NYKD closed today higher at kr2.61, an increase of 6.89% from yesterday's close, completing a monthly increase of 3.41% or kr0.09. Over the past 12 months, NYKD stock lost -13.71%.
NYKD is not paying dividends to its shareholders.
The last earnings report, released on Nov 26, 2025, exceeded the consensus estimates by 0.25%. On average, the company has surpassed earnings expectations by 0.18%, based on the last three reports. The next scheduled earnings report is due on Feb 25, 2026.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XBER (EUR).
NYKD Chart
Nykode Therapeutics ASA (NYKD) FAQ
What is the stock price today?
The current price is kr2.61.
On which exchange is it traded?
Nykode Therapeutics ASA is listed on XBER.
What is its stock symbol?
The ticker symbol is NYKD.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 351.77M.
When is the next earnings date?
The next earnings report will release on Feb 25, 2026.
Has Nykode Therapeutics ASA ever had a stock split?
No, there has never been a stock split.
Nykode Therapeutics ASA Profile
| Biotechnology Industry | Healthcare Sector | - CEO | XOSL Exchange | NO0010714785 ISIN |
| Germany Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
2025 © Marketlog. All Rights Reserved.
